InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Tsingos Christine A, Director. Insider active across 5 companies, notably Onto Innovation INC.. Aggregated, 17 reports have been published. Activity tracked since 11 May 2021. The latest transaction was filed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Tsingos Christine A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
9,330 shares0Common StockSEC:0001278861-26-000008:0
8,483 sharesCommon StockSEC:0001278861-26-000004:0
10,450 shares0Common StockSEC:0001628280-25-031063:0
6,573 sharesCommon StockSEC:0001681622-25-000031:0
10,085 shares0Common StockSEC:0001757073-24-000049:0
809 shares0Common StockSEC:0002022859-24-000020:0
46,752 shares0Common StockSEC:0000950170-24-053134:0
6,881 sharesCommon StockSEC:0001681622-24-000024:0
5,425 shares0Common StockSEC:0001757073-23-000045:0
2,200 shares0Common StockSEC:0001257815-23-000051:0
6,160 sharesCommon StockSEC:0001681622-23-000030:0
20,630 shares0Common StockSEC:0001850079-22-000049:0
4,435 shares0Common StockSEC:0001757073-22-000074:0
2,100 shares0Common StockSEC:0001407682-22-000055:0
5,098 sharesCommon StockSEC:0001681622-22-000022:0
4,020 shares0Common StockSEC:0001757073-21-000083:0
2,500 shares0Common StockSEC:0001407682-21-000084:0
17 of 17 declarations
About Tsingos Christine A
TSINGOS CHRISTINE A is Administrateur and has filed 17 disclosures in total. In the 17 sampled recent filings, the transactions are of Attribution nature, with buy and sell amounts of EUR 0, and the period runs from 2021-05-12 to 2026-05-21. The filings concern Envista Holdings Corp, Varex Imaging Corp, Onto Innovation INC., Telesis Bio Inc. and Codex DNA, Inc.
